Submitted by Anonymous (not verified) on 17 August 2023 - 13:54
Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised
Source: